AMLX Amylyx Pharmaceuticals, Inc. logo

AMLX Amylyx Pharmaceuticals, Inc.

Healthcare
$13.58-2.51%ClosedMarket Cap: $1.13B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

190

13F Shares

112,319,292

Ownership %

120.3%

New Positions

38

Increased Positions

110

Closed Positions

30

Reduced Positions

46

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
XPH395,4131.72%
PILLDirexion Daily Pharmaceutical & Medical Bull 3X ETF11,1261.25%
SBIOALPS Medical Breakthroughs ETF89,9831.00%
BBCVirtus Biotech Clinical Trials ETF20,8150.81%
FMEDFidelity Disruptive Medicine ETF23,5540.58%
KTD233,2800.31%
IHEiShares U.S. Pharmaceuticals ETF233,2800.31%
IWCiShares Micro-Cap ETF230,2650.25%
IJE230,2650.25%
VFMO162,7570.16%
IBBiShares Biotechnology ETF687,5360.11%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF43,2690.07%
VTWG63,0010.07%
IWOiShares Russell 2000 Growth ETF573,2500.06%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF31,0180.06%
NLO573,2500.06%
PRFZInvesco RAFI US 1500 Small-Mid ETF106,5030.05%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF79,6440.05%
VTWO439,5690.04%
JKKiShares Morningstar Small-Cap Growth ETF24,7260.04%